Archives for September 13, 2006

← 2006

Inhalable vaccine to inspire smokers to quit

By  Gregory Roumeliotis

A small spin-out company formed by the University of Colorado has been awarded a $850,000 (€670,000) grant from the US government to develop a dry powder inhalable version of Nabi's investigational injectable vaccine for nicotine addiction, boosting...

Xceleron moves in on $1bn US testing market

By  Emilie Reymond

Drug testing services provider Xceleron has set up new facilities in the US after regulations recently introduced by the Food and Drug Administration (FDA) are setting this industry sector ablaze.

How to avoid contract manufacturing disappointment

By  Kirsty Barnes

Successful technology transfer and effective management can help avoid disappointment with contract manufacturing arrangements, which often fail to live up to pharmaceutical company expectations.

Intercell's adjuvant stimulates Wyeth

By  Gregory Roumeliotis

Wyeth has entered into a global agreement that allows it to use Intracell's synthetic adjuvant IC31 in the formulation of five of its investigational vaccines, aiming to simply mix it with antigens without the need for conjugation.

Consolidation in Indian packaging market continues

By  Gregory Roumeliotis

India's Essel Propack, the largest speciality packaging company in the world, is acquiring Packaging India Private Limited (PIPL) from the CavinKare Group, keen to capture more of the country's booming pharmaceutical packaging market.

Manufacturers dodge EU wrath over counterfeits

By  Gregory Roumeliotis

European parliamentarians have come up with a long list of measures that the EU needs to take to combat counterfeit drugs, yet track and trace technologies were noticeably absent from their calls for action.